Johan M. J. Fevery

Johan M. J. Fevery's AcademicInfluence.com Rankings

Johan M. J. Fevery

Medical

#2609

World Rank

#3040

Historical Rank

Gastroenterology

#50

World Rank

#52

Historical Rank

medical Degrees

Johan M. J. Fevery

Philosophy

#7499

World Rank

#10721

Historical Rank

Logic

#4544

World Rank

#5853

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Johan M. J. Fevery's Degrees

Doctorate Medicine University of Amsterdam
PhD Gastroenterology University of Amsterdam

Why Is Johan M. J. Fevery Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Johan M. J. Fevery's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and management of primary sclerosing cholangitis (2010) (1097)
The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin (2006) (376)
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. (2017) (307)
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. (1997) (283)
Bilirubin in clinical practice: a review (2008) (245)
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure (2006) (244)
Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial (1997) (228)
Screening properties of questionnaires and laboratory tests for the detection of alcohol abuse or dependence in a general practice population. (2001) (215)
Assay and properties of dititonin-activated bilirubin uridine diphosphate glucuronyltransferase from rat liver. (1972) (205)
Current therapy for Crigler‐Najjar syndrome type 1: Report of a world registry (1996) (167)
Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery (2002) (159)
Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. (1976) (159)
Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat. (1988) (144)
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. (2013) (139)
The value of CAGE, CUGE, and AUDIT in screening for alcohol abuse and dependence among college freshmen. (2000) (138)
Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (2007) (134)
Long-term follow-up of chronic active hepatitis of moderate severity. (1978) (127)
Portal hypertension: from pathophysiology to clinical practice (2005) (126)
Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease. (1977) (125)
Variceal pressure is a factor predicting the risk of a first variceal bleeding: A prospective cohort study in cirrhotic patients (1998) (124)
Comparison in different species of biliary bilirubin-IX alpha conjugates with the activities of hepatic and renal bilirubin-IX alpha-uridine diphosphate glycosyltransferases. (1977) (117)
Franco‐Belgian Cooperative Study of Ursodeoxycholic Acid in the Medical Dissolution of Gallstones: A Double‐Blind, Randomized, Dose‐Response Study, and Comparison with Chenodeoxycholic Acid (1984) (110)
Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation (2001) (110)
The fate of bilirubin-IXalpha glucuronide in cholestasis and during storage in vitro. Intramolecular rearrangement to positional isomers of glucuronic acid. (1978) (109)
Arsenic and non-cirrhotic portal hypertension. A report of eight cases. (1990) (108)
Bilirubin conjugates in bile of man and rat in the normal state and in liver disease. (1972) (105)
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. (2000) (102)
Recent advances in the separation and analysis of diazo-positive bile pigments. (1974) (97)
In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats (2002) (97)
Incomplete septal cirrhosis: histopathological aspects (1988) (96)
Investigating the Origin and Spread of Hepatitis C Virus Genotype 5a (2006) (89)
Congenital veno‐venous malformations of the liver: Widely variable clinical presentations (2008) (88)
MELD score to predict outcome in adult patients with non‐acetaminophen‐induced acute liver failure (2007) (88)
Livers from Non–Heart-Beating Donors Tolerate Short Periods of Warm Ischemia (2005) (85)
Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long‐term single‐centre study (2012) (83)
Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. (1984) (82)
A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis (2005) (81)
Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver. (1984) (79)
Human Embryonic and Rat Adult Stem Cells with Primitive Endoderm-Like Phenotype Can Be Fated to Definitive Endoderm, and Finally Hepatocyte-Like Cells (2010) (78)
Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration. (1990) (74)
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited (2006) (70)
Early diagnosis of Budd-Chiari syndrome by computed tomography and ultrasonography: report of five cases. (1983) (70)
Review article: non‐biological liver support in liver failure (2006) (68)
Breast Cancer Resistance Protein (BCRP/ABCG2) Is Expressed by Progenitor Cells/Reactive Ductules and Hepatocytes and Its Expression Pattern Is Influenced by Disease Etiology and Species Type: Possible Functional Consequences (2006) (68)
Liver transplantation for polycystic liver disease (2001) (68)
Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. (1993) (68)
Treatment of acute hepatitis C with interferon α‐2b: early initiation of treatment is the most effective predictive factor of sustained viral response (2004) (67)
Thyroid hormones and the hepatic handling of bilirubin. I. Effects of hypothyroidism and hyperthyroidism on the hepatic transport of bilirubin mono‐ and diconjugates in the wistar rat (1989) (66)
Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide. (1995) (66)
Relationships between serum bilirubins and production and conjugation of bilirubin. Studies in Gilbert's syndrome, Crigler-Najjar disease, hemolytic disorders, and rat models. (1987) (65)
Fasting-related hyperbilirubinemia in rats: the effect of decreased intestinal motility. (1996) (63)
Immunohistochemical characterization of inflammatory infiltrates in primary biliary cirrhosis. (2008) (60)
Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells (2006) (58)
Characterization of the major diazo-positive pigments in bile of homozygous Gunn rats. (1977) (56)
Measurement of variceal pressure with an endoscopic pressure sensitive gauge: validation and effect of propranolol therapy in chronic conditions. (1996) (55)
Separation by thin-layer chromatography and structure elucidation of bilirubin conjugates isolated from dog bile. (1975) (55)
The effect of long‐term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites (1996) (55)
Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study. (1995) (55)
Gallbladder wall sonolucency in acute cholecystitis. (1979) (54)
Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia‐related syndrome (1994) (54)
Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients. (1976) (54)
Diagnosis and treatment of autoimmune hepatitis at age 65 and older (2005) (53)
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. (2007) (52)
A novel strand-specific RT-PCR for detection of hepatitis C virus negative-strand RNA (replicative intermediate): evidence of absence or very low level of HCV replication in peripheral blood mononuclear cells. (2002) (52)
Intestinal colonization leading to fecal urobilinoid excretion may play a role in the pathogenesis of neonatal jaundice. (2000) (52)
Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. (1994) (51)
Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. (1991) (51)
Excretion in dog bile of glucose and xylose conjugates of bilirubin. (1971) (50)
Treatment of decompensated viral hepatitis B-induced cirrhosis with low doses of interferon alpha. (2008) (49)
Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients. (1998) (49)
Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension (1999) (49)
Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls (2003) (48)
Focal liver lesions: fast T2-weighted MR imaging with half-Fourier rapid acquisition with relaxation enhancement. (1996) (47)
What can we learn from analysis of serum bilirubin? (1986) (47)
Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System (2003) (46)
Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection. (1994) (46)
Quantitative hepatitis B virus DNA assessment by the limiting‐dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy (1998) (45)
Intestinal Excretion of Unconjugated Bilirubin in Man and Rats with Inherited Unconjugated Hyperbilirubinemia (1997) (45)
Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study. (2012) (45)
Percutaneous transhepatic cholecystostomy for acute complicated cholecystitis in elderly patients. (1990) (44)
Liver enzyme elevation induced by hyperemesis gravidarum: aetiology, diagnosis and treatment. (2002) (44)
Effect of phenobarbitone on plasma (14C)bilirubin clearance in patients with unconjugated hyperbilirubinaemia. (1974) (43)
Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses (2006) (43)
Patients with large‐duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD (2016) (43)
Hepatitis C virus genotypes: epidemiological and clinical associations (2008) (43)
Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial (2006) (42)
Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis. (2009) (41)
Oxidative breakdown of octanoic acid is maintained in patients with cirrhosis despite advanced disease (2003) (41)
'Lupus' anticoagulant and thrombosis of the hepatic veins (Budd-Chiari syndrome). Report of three patients and review of the literature. (1986) (41)
Both Ca2+ -dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine. (2007) (41)
Serum bilirubins in hepatobiliary disease: Comparison with other liver function tests and changes in the postobstructive period (1985) (40)
Primary graft nonfunction and Kupffer cell activation after liver transplantation from non‐heart‐beating donors in pigs (2007) (40)
Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. (2005) (39)
Effect of clofibrate on the metabolism of bilirubin, bromosulphophthalein and indocyanine green and on the biliary lipid composition in Gilbert's syndrome. (1984) (39)
Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. (1990) (39)
Steroid‐free immunosuppression during and after liver transplantation – a 3‐yr follow‐up report (2003) (39)
Gallbladder wall thickening: A new sign of gallbladder disease visualized by gray scale cholecystosonography (1978) (38)
Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature (2002) (36)
Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha‐2b interferon is not a predictor for sustained response to treatment (1994) (35)
QUESTIONNAIRES ARE BETTER THAN LABORATORY TESTS TO SCREEN FOR CURRENT ALCOHOL ABUSE OR DEPENDENCE IN A MALE INPATIENT POPULATION (2002) (35)
Liver transplantation using cavoportal transposition: an effective treatment in patients with complete splanchnic venous thrombosis. (2005) (35)
Liver fatty acid-binding protein: an early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors. (2005) (35)
The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices. (1995) (34)
Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection (1999) (34)
Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection. (2003) (34)
The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis. (1994) (34)
Subfractionation of serum bilirubins by alkaline methanolysis and thin-layer chromatography. An aid in the differential diagnosis of icteric diseases. (1990) (34)
Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia (2005) (34)
Giant liver hemangioma: the role of female sex hormones and treatment. (2011) (33)
Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non‐cirrhotic patients (2000) (32)
CC‐Type chemokine receptor 5‐&Dgr;32 mutation protects against primary sclerosing cholangitis (2006) (32)
Biliary cirrhosis induces type IIx/b fiber atrophy in rat diaphragm and skeletal muscle, and decreases IGF-I mRNA in the liver but not in muscle. (1998) (32)
Hepatitis B surface antigen (HBsAg) in the liver of patients with hepatitis; a comparison with serological detection. (1976) (32)
Glucuronidation of bilirubin and the occurrence of pigment gallstones in patients with chronic haemolytic diseases (1971) (32)
Enzymic transfer of glucose and xylose from uridine diphosphate glucose and uridine diphosphate xylose to bilirubin by untreated and digitonin-activated preparations from rat liver. (1972) (32)
Simultaneous macroamylasemia and macrolipasemia. (1994) (32)
Ulcerative colitis, primary sclerosing cholangitis, bile duct carcinoma, and generalized sarcoidosis. Report of a unique association. (1987) (31)
Detection of Pi Z phenotype individuals by alpha-1-antitrypsin (AAT) immunohistochemistry in paraffin-embedded liver tissue specimens. (1986) (31)
Chromatographic analysis and structure determination of biliverdins and bilirubins. (1989) (30)
Endoscopic Biliary Endoprosthesis in Elderly Patients with Large Bile Duct Stones: Long‐Term Follow‐Up (1992) (30)
Aggregated colon cancer cells have a higher metastatic efficiency in the liver compared with nonaggregated cells: an experimental study. (2003) (29)
Percutaneous Transhepatic Cholecystostomy for Acute Complicated Calculous Cholecystitis in Elderly Patients (1993) (28)
Quantitation of urobilinogen in feces, urine, bile and serum by direct spectrophotometry of zinc complex. (1991) (28)
Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies. (2002) (28)
Cholestatic action of somatostatin in the rat: Effect on the different fractions of bile secretion (1981) (28)
Maximal biliary secretion of bilirubin in the anaesthetized rat: dependence on UDP-glucuronosyltransferase activity. (1982) (28)
Alpha-1-antitrypsin (AAT) and its stimulation in the liver of PiMZ phenotype individuals. A "recruitment-secretory block" ("R-SB") phenomenon. (2008) (28)
Relationships between serum bilirubins and production and conjugation of bilirubin (1987) (27)
Expression of hepatitis C virus core protein impairs DNA repair in human hepatoma cells. (2004) (27)
Sex differences of hepatic conjugation of bilirubin determine its maximal biliary excretion in non-anaesthetized male and female rats. (1983) (27)
Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself (2002) (27)
Pathogenesis of Gilbert's syndrome (1981) (26)
Thyroid hormones and the hepatic handling of bilirubin. II. Effects of hypothyroidism and hyperthyroidism on the apparent maximal biliary secretion of bilirubin in the Wistar rat. (1988) (26)
Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine (2010) (26)
Hepatic osteodystrophy in rats results mainly from portasystemic shunting (2003) (25)
Primary human hepatocytes are protected against prolonged and repeated exposure to ethanol by silibinin-dihemisuccinate. (2003) (25)
Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver. (1980) (25)
Vitamin A abuse: development of cirrhosis despite cessation of vitamin A. A six-year clinical and histopathologic follow-up. (2008) (24)
An update on cholangiocarcinoma associated with primary sclerosing cholangitis (2010) (24)
Hepatic echinococcosis ruptured into the biliary tract. Clinical, radiological and therapeutic features during five episodes of spontaneous biliary rupture in three patients with hepatic hydatidosis. (1987) (24)
LIVER TRANSPLANTATION USING LIVERS FROM SEPTUAGENARIAN AND OCTOGENARIAN DONORS: AN UNDERUSED STRATEGY TO REDUCE MORTALITY ON THE WAITING LIST. (2004) (24)
Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor. (1999) (23)
Pericardial disease is often not recognised as a cause of chronic severe ascites. (2000) (23)
Mass-spectrometric structure elucidation of dog bile azopigments as the acyl glycosides of glucopyranose and xylopyranose. (1971) (23)
Is there a difference between CAGE interviews and written CAGE questionnaires? (2000) (23)
Critique of the assay and significance of bilirubin conjugation. (1973) (23)
Congenital dilatation of the intrahepatic bile ducts associated with the development of amyloidosis (1972) (23)
Are Nuclear Particles Specific for Non‐A, Non‐B Hepatitis? (2007) (22)
Structures of bilirubin conjugates synthesized in vitro from bilirubin and uridine diphosphate glucuronic acid, uridine diphosphate glucose or uridine diphosphate xylose by preparations from rat liver. (1972) (22)
Fasting hyperbilirubinemia: unraveling the mechanism involved. (1997) (22)
Analytic aspects and clinical interpretation of serum bilirubins. (1988) (22)
Potential role of bile duct collaterals in the recovery of the biliary obstruction: Experimental study in rats using microcholangiography, histology, serology and magnetic resonance imaging (1994) (21)
Dilatation of the cystic veins in portal hypertension: sonographic demonstration. (1985) (21)
Prognostic significance of piecemeal necrosis in acute viral hepatitis. (2008) (21)
Hyperbilirubinemia: significance of the ratio between direct-reacting and total bilirubin. (1967) (21)
Hepatitis G virus infection in acute fulminant hepatitis: prevalence of HGV infection and sequence analysis of a specific viral strain (1998) (21)
Effects of varying doses of spironolactone without and with nitrates on portal vein pressure and kidney function in partial portal vein ligated rats (1996) (21)
Hereditary hyperferritinaemia-cataract syndrome: a challenging diagnosis for the hepatogastroenterologist. (2005) (21)
HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development. (2007) (20)
Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologie. (1998) (20)
Human non-A, non-B hepatitis: ultrastructural alterations in hepatocytes. (2008) (20)
Effects of ioglycamide on the hepatic transport of bilirubin and its mono‐ and diconjugates in the rat (1985) (20)
Oesophageal varices: Assessment of the risk of bleeding and mortality (2000) (20)
Cholestatic action of somatostatin in the rat: effect on the different fractions of bile secretion. (1981) (20)
Combined ‘En Bloc’ Liver and Pancreas Transplantation in Patients with Liver Disease and Type 1 Diabetes Mellitus (2004) (19)
How should mild, isolated unconjugated hyperbilirubinemia be investigated? (1983) (19)
The Molecular Adsorbent Recirculating System in patients with severe liver failure: clinical results at the K.U. Leuven. (2002) (19)
Varicella-zoster virus infection associated with acute liver failure. (1998) (18)
Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. (1998) (18)
Does ex vivo vascular resistance reflect viability of non-heart-beating donor livers? (2005) (18)
Cystadenoma of the common bile duct demonstrated by endoscopic retrograde cholangiography: an uncommon cause of extrahepatic obstruction. (1984) (18)
Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature. (2008) (17)
Biliary lipid composition in patients with nonoperated Crohn's disease (2005) (16)
Somatostatin inhibits the effect of secretin on bile flow and on hepatic bilirubin transport in the rat. (1989) (16)
Renal bilirubin clearance in liver patients. (1967) (16)
Is HBV genotyping of clinical relevance? (2005) (16)
Gastric leiomyoblastoma with metastases to the liver. A 36-year follow-up study. (1985) (16)
Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine). (1988) (15)
Bilirubin‐IX α and ‐IX β pigments, coproporphyrins and bile acids in meconium and stools from full‐term and preterm neonates during the first month of life (2001) (15)
Benelux multicentre trial of alpha interferon treatment for chronic hepatitis C: standard v high dose treatment monitored by biochemical and virological markers (interim analysis). Benelux Multicentre Trial Study Group. (1993) (15)
Subtotal Resection of the Head of the Pancreas Combined with Ductal Obliteration of the Distal Pancreas in Chronic Pancreatitis (1987) (15)
Enhancement by Secretin of the Apparently Maximal Hepatic Transport of Bilirubin in the Rat (1984) (15)
Rapid protocol for electroporation of Clostridium perfringens. (2005) (15)
Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis. (1996) (14)
Bilirubin Metabolism and Hyperbilirubinemia (1992) (14)
The origins and kinetics of bilirubin in dogs with hepatobiliary and haemolytic diseases. (1992) (14)
AASLD PRACTICE GUIDELINES Diagnosis and Management of Primary Sclerosing Cholangitis (2010) (14)
The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B. (2001) (14)
TT virus infection in acute and chronic liver diseases and in patients regularly receiving blood products in Belgium. (2004) (14)
HEPATITIS C AND INSULIN RESISTANCE: MUTUAL INTERACTIONS. A REVIEW (2007) (14)
Identification of HepG2 variant cell lines by short tandem repeat (STR) analysis (2004) (14)
Bilirubin conjugates: formation and detection. (1976) (14)
Halofuginone can worsen liver fibrosis in bile duct obstructed rats (2004) (13)
Effects of uridine diphosphate glucuronosyltransferase activity on the maximal secretion rate of bilirubin conjugates in the rat. (1990) (13)
Unconjugated and conjugated bilirubin pigments during perinatal development. II. Studies on serum of healthy newborns and of neonates with erythroblastosis fetalis. (1990) (13)
The action of VIP on bile secretion and bile acid output in the non-anaesthetized rat. (1985) (13)
Treatment of acute hepatitis C with interferon alpha 2b prevents chronicity. (1999) (13)
Endoscopic sclerotherapy of esophageal varices. Long-term follow-up, recurrence, and survival. (1988) (13)
Cimetidine-induced liver injury. Report of three cases. (1985) (12)
Sclerotherapy of oesophageal varices after variceal haemorrhage. (1984) (12)
Ultrasound and CT of multifocal liver abscesses caused by Yersinia enterocolitica. (1989) (12)
An unusual case of Crigler-Najjar disease in the adult. Classification into types I and II revisited. (1985) (12)
NO Synthase in the Liver: Prospects of in vivo Gene Transfer (1998) (12)
TTV infection and its relation to serum transaminases in apparently healthy blood donors and in patients with clotting disorders who have been investigated previously for hepatitis C virus and GBV‐C/HGV infection in Belgium (2002) (12)
Statins in hepatobiliary diseases: effects, indications and risks. (2007) (12)
New ultrastructural marker in hepatocytes in non-A, non-B viral hepatitis. (2008) (12)
Conjugation of N-acetyl-p-aminophenol (N.A.P.A.) in adult liver patients. (1969) (11)
Fatty Liver Hepatitis and Type 5 Hyperlipoproteinemia in Juvenile Diabetes Mellitus: Case Report and Review of the Literature (1990) (11)
Stimulation by secretin of bilirubin UDP-glycosyltransferase activities and of cytochrome P-450 concentration in rat liver. (1979) (11)
Ultrasonography of liver haemangioma. A report of 35 patients totalizing 53 lesions. (1983) (11)
Primary sclerosing cholangitis in two brothers: report of a family with special emphasis on molecular HLA and MICA genotyping. (2005) (11)
Effect of narcotic agents and of bleeding on systemic and renal haemodynamics in healthy and CCl4-treated cirrhotic rats. (1997) (11)
10 Liver biopsy (1995) (10)
Elevation of the serum bilirubin diconjugate fraction provides an early marker for cholestasis in the rat. (1997) (10)
Serum Bilirubin Mono- and Diconjugates in Human Newborns (1984) (10)
Clinical evaluation of the liver cell membrane autoantibody assay. (1982) (10)
Pancreatic cancer: a plea for more trials. (1995) (10)
Hepatitis B core antigen immune complexes in the liver of hepatitis B patients. (1979) (10)
Surgical strategy in liver transplantation for polycystic liver disease. (2001) (10)
Percutaneous Transhepatic Cholangioscopy for Diagnosis and Therapy of Biliary Diseases in Older Patients (1996) (9)
The sonographic aspects of haemobilia. Clinical and experimental study. (1985) (9)
Bilirubin-IXbeta is a marker of meconium, like zinc coproporphyrin. (2001) (9)
NONIATROGENIC HAEMOCHROMATOSIS IN CONGENITAL DYSERYTHROPOIETIC ANAEMIA TYPE II IS NOT RELATED TO C282Y AND H63D MUTATIONS IN THE HFE GENE : REPORT ON TWO BROTHERS (2002) (9)
Urobilinogen-i is a major derivative of bilirubin in bile of homozygous Gunn rats. (1990) (8)
Storage of alpha‐1‐antitrypsin in intrahepatic bile duct cells in alpha‐1‐antitrypsin deficiency (Pi Z phenotype) (1985) (8)
Severe intrahepatic cholestasis due to the combined intake of oral contraceptives and triacetyloleandomycin. (1983) (8)
Plasma bilirubin pigments in health and disease. (1987) (8)
Selection criteria and outcome of patients referred to intestinal transplantation: an European center experience. (2006) (8)
Unconjugated and conjugated bilirubin pigments during perinatal development. I. Studies on rat serum and intestine. (1986) (8)
Postoperative biliocutaneous fistula: successful treatment by insertion of an endoprosthesis. (1987) (8)
Unconjugated hyperbilirubinaemia in achalasia (1974) (7)
Bilirubin-like material in urine of normal adults. (1968) (7)
Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C. (1995) (7)
Increased serum phospholipase A2 activity after non-heart-beating donor liver transplantation and association with ischemia-reperfusion injury. (2009) (7)
Culture of Mouse Embryonic Stem Cells with Serum but without Exogenous Growth Factors Is Sufficient to Generate Functional Hepatocyte-Like Cells (2011) (7)
Comparative histology of acute hepatitis B and non-A, non-B in Leuven and Padova (2004) (7)
Detection and properties of the non-alpha-isomers of bilirubin-IX. (1977) (7)
The influence of gestational age on bilirubin conjugation in newborns (1991) (7)
The maximal biliary excretory rate (Tm) of ioglycamide in the rat. Effect of taurocholate. (1985) (7)
Simultaneous alpha-1-antitrypsin accumulation in liver and pancreas. (1984) (7)
Enzymic formation of beta-D-monoglucuronide, beta-D-monoglucoside and mixtures of beta-D-monoxyloside and beta-D-dixyloside of bilirubin by microsomal preparations from rat liver. (1971) (7)
Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation. (2001) (7)
Case report: fourteen-year follow-up of an apudoma of the bile ducts at the hilum of the liver. (1983) (7)
Hepatocellular carcinoma in a case of familial polyposis coli. (1989) (7)
Quantitation of Hepatic Bilirubin Conjugation (1973) (7)
Properties of bilirubin UDP-glycosyltransferases. (1976) (7)
Endoscopic biliary endoprosthesis as definitive treatment of elderly patients with large bile duct stones. (1987) (7)
Early derivation operation can restore the pancreas histology and function in chronic obstructive pancreatitis in the cat. (1998) (6)
Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women. (2012) (6)
Effect of MARS and PROMETHEUS on systemic hemodynamics and vasoactive agents in patients with acute on-chronic alcoholic liver failure: the clash of the titans (2005) (6)
Methods of determination and nature of diazo-positive bile pigments present in body fluids in neonatal jaundice and related conditions. (1976) (6)
Measurement of variceal pressure and its clinical implications. (1994) (6)
Perinatal development of bilirubin UDP-glycosyltransferase activities in rat liver. (1977) (6)
Bilirubin-IXalpha and -IXbeta pigments, coproporphyrins and bile acids in meconium and stools from full-term and preterm neonates during the first month of life. (2001) (6)
Damage to duct epithelium is necessary to develop progressing lesions of chronic pancreatitis in the cat. (1996) (6)
A light microscopic marker of non-A, non-B viral hepatitis. (1981) (6)
Intramural hematoma of the esophagus: Unusual complication of variceal sclerotherapy (2005) (6)
CT demonstration of right hepatic lobe atrophy. (1989) (6)
Increase in the relative amount of bilirubin diconjugates in rat bile and serum under infusion of phthaleins and indocyanine green. (1990) (6)
Radiologic investigations and pathologic results of experimental chronic pancreatitis in cats. (1998) (6)
Focal fatty infiltration of the liver associated with important mass effect. (1994) (5)
Renal clearance of bilirubin conjugates in newborns of different gestational age (1993) (5)
The value of computed tomography, ultrasonography, and peritoneoscopy with biopsy in the detection of liver metastases secondary to gastro-enterological tumors. (1985) (5)
Quantitation of replication of the HCV genome in human livers with end‐stage cirrhosis by strand‐specific real‐time RT‐PCR assays: Methods and clinical relevance (2009) (5)
The origins and kinetics of bilirubin in healthy dogs, in comparison with man. (1992) (5)
O5 PRIMARY SCLEROSING CHOLANGITIS FROM A GLOBAL PERSPECTIVE – A MULTICENTER, RETROSPECTIVE, OBSERVATIONAL STUDY OF THE INTERNATIONAL PSC STUDY GROUP (2014) (5)
Validation of immunohistochemical staining with the monoclonal antibody 17H10 in liver biopsies for the diagnosis of chronic hepatitis C (2000) (5)
Pigment gallstones in Crohn's disease. (1999) (5)
The bilirubin diglucuronide controversy. (1985) (5)
Maximal hepatic bilirubin transport in the rat during somatostatin-induced cholestasis and taurocholate-choleresis. (1983) (5)
Hepatic osteodystrophy: the influence of liver disease and portal hypertension on cytokine activation. (2000) (5)
Excretion of bilirubin conjugated with glucose in dog bile. (1970) (5)
gender and Ibd phenotype are independent predictors of death or transplantation and of malignancy in Primary Sclerosing Cholangitis - a multicenter retrospective study of the International Psc Study Group (ipscsg) : 76 (2015) (5)
Altered composition of bilirubin conjugates in rat bile after obstruction of the common bile duct (2005) (5)
Complete recovery from hepatitis B and associated hemolysis in a patient with underlying T-cell deficiency. (1984) (5)
The RANTES −28 g polymorphism is associated with primary sclerosing cholangitis (2007) (5)
Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation. (2010) (5)
Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal (ABOVE) randomised trial (1998) (5)
[Prevalence of alcohol abuse and alcohol dependence according to DSM-IV criteria in first year university students]. (1999) (4)
Bilirubin-binding properties of plasma and liver cytosol preparations from rats. (1972) (4)
Asymmetric dimethylargine (ADMA) is involved in portal hypertension of biliary but not of toxic cirrhotic rats (2005) (4)
Treatment of acute esophageal variceal bleeding: a review (1999) (4)
Stricker, B. H. C., ed. Drug-induced hepatic injury. 2nd edn. Drug induced disorders, Volume 5. (2008) (4)
Bile pigment metabolism. (1989) (4)
Non-A, non-B hepatitis in man: further evidence in favour of hepatitis-B like particles. (2008) (4)
Non-surgical treatment of hepatocellular carcinoma (HCC). (2000) (4)
Liver transplantation: problems and perspectives. (1998) (4)
[Malignant tumors of the liver]. (1972) (4)
Erythromycin-induced hepatitis: simulator of malignancy. (1988) (4)
Quantitative aspects of the effect of somatostatin on bile flow in the rat [proceedings]. (1980) (3)
Glucagon enhances bile flow, bilirubin uridine diphosphate-glucuronyltransferase activity and biliary bilirubin monoconjugate excretion in the rat. (1992) (3)
Non-A, non-B hepatitis-like nuclear particles in nonparenchymal cells of the liver. (1984) (3)
Treatment of rats with glucagon, vasointestinal peptide or secretin has a different effect on bilirubin and p-nitrophenol UDP-glucuronyltransferase. (1988) (3)
Patients transplanted for hepatitis C should not receive livers from older donors (2001) (3)
A comparative study of angiography and dynamic computed tomography in liver angioma. A report of 15 cases. (1982) (3)
In vivo gene transfer of NO synthase reduces portal pressure in experimental cirrhosis in rats (1996) (3)
Diagnosis and pathogenetic mechanisms of liver diseases (1990) (3)
Cenos gene transfer enhances no production and nos protein expression in the CCL4 cirrhotic rat liver resulting in prolonged decrease of portal pressure (2000) (3)
Outcome in Caucasian patients with hepatitis B e antigen negative chronic infection: A long‐term observational cohort study (2020) (3)
Distal common bile duct stenosis secondary to benign duodenal ulceration: Report of a case (2005) (3)
Three cases of non-tumoural tight stenosis of the bifurcation of the hilar bile ducts. (1994) (3)
Comparative study of low power neodymium-YAG laser interstitial hyperthermia versus ethanol injection for controlled hepatic tissue destruction (2005) (2)
Comparative Studies on the Structures of Conjugated Bilirubin-IXα and Changes in Cholestasis (1976) (2)
Presence of bilirubin-ix-beta, bilirubin-ix-gamma and bilirubin-ix-delta in bile of man and various animals (1975) (2)
In vitro assays for drug testing: continuous cell lines. (2000) (2)
Combination therapy of nitrates and spironolactone in experimental portal hypertension (1995) (2)
189 Improvement in systemic hemodynamics after mars is associated with a decrease in vasoactive substances in patients with acute on chronic liver failure (AOCLF): Results of a randomised trial (2004) (2)
Long-term follow-up of mild chronic active hepatitis. (1987) (2)
Physiology and Disorders of Human Bilirubin Metabolism (2018) (2)
Nitroflurbiprofen (HCT-1026), a nitric oxidereleasing cyclooxygenase-inhibitor, improves cirrhotic portal hypertension in the rat without major side-effects (2006) (2)
Enhanced co-experession of eNOS and iNOS in dilated sinusoids in advanced primary biliary cirrhosis, suggests a role for these NOS isoforms in intrahepatic portohepatic blood shunting (2000) (2)
Liver biopsy. (1995) (2)
Distribution patterns ofhepatitis Bsurface antigen (HBsAg) intheliver ofhepatitis patients (1976) (2)
Lipiodol-Cisplatin embolisation in hepatocellular carcinoma. Radiological techinique and evaluation (1991) (2)
Different expression of NO synthase in human cirrhotic liver specimens may be related to different mechanisms of portal hypertension (1996) (2)
Amoebic liver abscess. Report of 5 cases. (1983) (2)
Hypothermic machine persfusion of porcine livers (2005) (2)
Detection of HCV antigen by immunohistochemical staining: a histological marker of HCV infection (1991) (2)
Ascites: medical therapy and paracentesis. (1996) (2)
Altered composition of bilirubin conjugates in the bile after obstruction (1971) (2)
Hepatic stellate cell contraction: (myo)fibroblast-like or smooth muscle cell-like? (2005) (2)
EARLY DIAGNOSIS OF BUDD-CHIARI SYNDROME BY COMPUTED TOMOGRAPHY AND ULTRASONOGRAPHY: REPORT OF FIVE CASES (1983) (2)
Sex difference of hepatic conjugation of bilirubin determines its maximal biliary excretion in male and female rats (1983) (2)
severity . active hepatitis of moderate Long-term follow-up of chronic (2006) (2)
Determination of unconjugated and total N-acetyl-p-aminophenol (NAPA) in urine and serum. (1967) (2)
TREATMENT OF CHRONIC HEPATITIS WITH AZATHIOPRINE AND PREDNISONE COMBINED (1971) (1)
The effect of spironolactone on variceal pressure in man and on portal pressure in the cirrhotic rat (1996) (1)
Serum bilirubin pigments: methods and clinical interpretation. (1988) (1)
Clinical aspects of incomplete septal cirrhosis (1990) (1)
Effects of conjugation, bile flow and bile acid load on the apparent maximal secretion of bilirubine ("Tm") (1979) (1)
Arsenic and non-cirrhotic portal hypertension: report of 8 cases (1990) (1)
[Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients]. (1996) (1)
Incomplete septal cirrhosis (ICS),a syndrome intermediate between cirrhosis and obliterative portal venopathy (1991) (1)
Relevance of detecting additional small HCC lesions prior to liver transplantation (2003) (1)
Machine perfusion of marginal livers (2005) (1)
379 Expression of hepatitis C virus core protein impairs DNA-repair in human hepatoma cells (2004) (1)
Somatostatin for acute oesophageal variceal bleeding (1998) (1)
Detection of Hcv Antigen and Hcv-rna in Liver Biopsies of Patients With Chronic Hepatitis-c Undergoing Liver-transplantation - a Close Correlation (1993) (1)
In the CCL4 cirrhosis but not prehepatic portal hypertension or biliary cirrhosis, a reduced expression of ceNOS is found in rat liver (2000) (1)
Taurocholate increases the biliary output of bilirubin pigments in the rat, due to haemolysis. (1989) (1)
Some pathophysiological aspects of cholestasis. (1979) (1)
Aplastic anemia after transplantation for non‐A, non‐B, non‐C fulminat hepatic failure: case report and review of the literature (2002) (1)
The response of the variceal pressure to pharmacotherapy predicts the risk of variceal bleeding in cirrhotic patients (1999) (1)
Sonographic diagnosis of intraluminal bile duct neoplasm: A report of 3 cases (2005) (1)
Clinical Significance of Recent Developments in Serum Bilirubins (1989) (1)
[Liver cirrhosis and cholangiocarcinoma following Thorotrast administration]. (1979) (1)
Effect of terlipressin on portal pressure and on renal function in cirrhotic rats (1996) (1)
The level of variceal pressure is a major predictor for variceal hemorrhage both in patients with cirrhosis as in patients with non-cirrhotic portal hypertension (1998) (1)
[Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates]. (1980) (1)
Lincomycin treatment of guinea pigs causes formation of pigmented phosphate containing gallbladder sludge and stones. (1989) (1)
Miscellaneous liver disorders (1994) (1)
Addition of epoprostenol (Epo) into the pressurized UW reduces the incidence of biliary stricture (BS) after liver transplantation (LTX) (2001) (1)
Discriminative and prognostic factors in acute liver cell failure treated by exchange transfusion (1970) (1)
Less Active Chronic Hepatitis (1976) (1)
HLA-DR expression in Hepatitis B Virus infection (1987) (1)
Central role of Kupffer cell in ischemic injury following transplantation of non-heart-beating livers (2005) (1)
Clinical Biochemistry in Hepatobiliary Diseases (1989) (1)
Low doses of spironolactone reduce portal vein pressure without affecting plasma volume in the rat (1996) (1)
[Pathogenesis of cholesterol stones in the gallbladder]. (1986) (1)
Fate of bilirubin-9alpha glucuronides in cholestasis (1976) (1)
Methotrexate alone or in combination with ursodeoxycholic acid as possible treatment in primary biliary cirrhosis (1994) (1)
Leversteatose, niet-alcoholische steatohepatitis en insulineresistentie: pathogenese, diagnose en therapie (2007) (1)
Type of aortic preservation solution and not cold ischemia is a major determinant of biliary stricture (BS) after liver transplantation (LTx) (1999) (1)
Separation of bilirubin-binding factors from rat liver cytosol by centrifugation and electrophoresis in density gradients. (1972) (1)
Characterization of bilirubin pigments in bile of neonates and of children with crigler-najjar disease (1976) (1)
The mechanism of fasting hyperbilirubinaemia in gunn rats (1991) (1)
Primary sclerosing pancreatitis. Chronic pancreatitis associated with inflammatory bowel disease, a distinct entity (1986) (1)
Morphological markers of human non-A, non-B hepatitis (1982) (0)
[Carbohydrate metabolism and treatment of hepatic diseases by steroids. Clinical study]. (1967) (0)
Thromboxane A2 affects the increased intrahepatic vascular tone of rats with cirrhotic portal hypertension, in part through interaction with nitric oxide production (2006) (0)
Subtotal pancreatic head resection combined with left pancreatic duct obstruction in chronic pancreatitis. (1985) (0)
328 Sympathetic nervous system inhibition, in acute and chronic CCL4 intoxication, results in inhibition of hepatic stellate cells/myofibroblasts and stimulation of hepatic progenitor cells (2004) (0)
Patients with fundal variceal bleeding have frequently large portosystemic shunts which makes them at risk for thrombosis and encephalopathy after tips (1999) (0)
Severe colitis in young male adults transplanted for PSC (2004) (0)
Warren shunt for portal hypertension due to idiopathic portal vein thrombosis: back to shunt-surgery (2005) (0)
Porta-systemic shunting in the presence of normal liver function causes osteopenia in the rat (1999) (0)
Predictors of IBD exacerbations after liver transplantation in patients with PSC and IBD (2014) (0)
Bleeding from anorectal varices, a rare but frequently lethal complication of liver cirrhosis (1998) (0)
[II. Activation and inhibition of glucuronidation by the liver]. (1968) (0)
The t1/2 value of 13C-octanoic acid excretion is not changed in cirrhotic patients (2001) (0)
A comparative analysis of the HCV genotype 5a molecular epidemiology in Belgium and South Africa (2006) (0)
Choleresis and cholestasis (1990) (0)
IMPROVED OUTCOME OF LIVER TRANSPLANTATION FOR HEPATITIS C IN A MORE RECENT ERA. (2004) (0)
LIVER TRANSPLANTATION USING CAVO-PORTAL TRANSPOSITION: AN EFFECTIVE TREATMENT IN PATIENTS WITH COMPLETE SPLANCHNIC VENOUS THROMBOSIS (2004) (0)
Liver transplantation (LTx) without steroids (1999) (0)
Concentrations of gentamicin in ascitic fluid after intravenous infusion. (1983) (0)
Characterization of bilirubinoid pigments in bile of children with crigler-najjar disease (cn) and of homozygous gunn rats - effect of phototherapy (1976) (0)
The value of immunohistochemical staining with a monoclonal antibody against HCV-E2 to study HCV reinfection and the effect of treatment post-LTx (2002) (0)
En bloc cluster liver-pancreas transplantation (CLPTx): new non-malignant indications for an operation described a decade ago (2001) (0)
Patients with alcoholic liver disease often have preserved peripheral antioxidant levels despite ongoing oxidative liver damage (2001) (0)
Bilirubin-IX&bgr; Is a Marker of Meconium, Like Zinc Coproporphyrin (2001) (0)
Liverscintigraphy in the detection of metastatic carcinoma. (1973) (0)
The kidney in liver disease (2008) (0)
Pancreatic ascites. (1984) (0)
The pathogenesis of hepatic osteodystrophy might be related to tumor necrosis factor alpha (TNF) activation (1999) (0)
Activated intestinal macrophag release NO and IL-6 that may disrupt intestinal barrier function (2013) (0)
Meld score predicts the risk of death in patients with non-acetaminophen-induced acute liver failure (2005) (0)
A potential therapeutical procedure in unconjugated hypersilirubinemia (1990) (0)
Malondialdehyde as a good marker of oxidative stress in liver diseases (1999) (0)
Cholestatic liver disease (1991) (0)
New ultrastructural marker in non-A, non-B viral hepatitis (1982) (0)
De kwaadaardige tumoren van de anale streek (1970) (0)
Formalin injection into the bile duct together with bile duct excision induced a stable model to study portal hypertension in biliary cirrhosis (2000) (0)
New clinical aspects of bilirubin metabolism. (1985) (0)
Recent developments in Biluribin conjugation (1972) (0)
Levercirrhose en cholangiocarcinoma na thorotrasttoediening (1979) (0)
Octreotide stimulates the free water clearance in healthy and cirrhotic rats (1996) (0)
Sumatriptan reduces variceal pressure without affecting portal pressure (1999) (0)
Hepatic osteodystrophy. (2003) (0)
Terlipressin enhances free water clearance in experimental cirrhosis in the rat (1995) (0)
Quantitation of bilirubin metabolism. (1985) (0)
Effects of drugs and of bilirubinostasis on glucuronidation of bilirubin (1988) (0)
Effect of Hepatitis B virus replication on oxidative stress, gene expression and induction of genetic changes in an inducible cell culture model of HepAD38 cells (2005) (0)
Liver transplantation (LTx): results, progresses and remaining problems. An analysis based on 500 LTx in a 10-year period (2008) (0)
Liver Editorial overview (1990) (0)
Liver transplantation without steroids (1999) (0)
[I. The glucuronidase function of the liver]. (1968) (0)
Contents, Vol. 32, 1977 (1977) (0)
Gene transfer of ceNOS induces long-term control of portal hypertension in CCl4 cirrhotic rats (1998) (0)
Combination therapy of nitrates and spironolactone in the treatment of portal hypertension (1996) (0)
No immune graft loss under an AB initio steroid-free immunosuppressive protocol: a two year follow-up (2001) (0)
[Liver cysts: review]. (1972) (0)
Structure Elucidation ofDogBile Azopigments astheAcylGlycosides ofGlucopyranose andXylopyranose (1971) (0)
[Should we treat cirrhosis in hepatitis C carriers with antiviral agents?]. (1999) (0)
LIVER FATTY ACID-BINDING PROTEIN: AN EARLY AND SENSITIVE SERUM MARKER OF HEPATOCELLULAR DAMAGE AND A RELIABLE PREDICTOR OF GRAFT VIABILITY AFTER LIVER TRANSPLANTATION FROM NON-HEART-BEATING DONORS. (2004) (0)
The effect of selective vagotomy on the hepatic stellate cell/myofibroblast subpopulations in acute galactosamine intoxication in rat (2002) (0)
Biliary cirrhosis induces type IIb/IIx atrophy in rat diaphragm (1996) (0)
[Biochemical basis of the effects of alcohol]. (1976) (0)
Endothelial dysfunction in cirrhotic rat livers may involve both NO and superoxide (2001) (0)
Liver transplantation (LTx). for polycystic liver disease (PLD) (1999) (0)
[Aggressive chronic hepatitis and non-alcoholic cirrhosis of moderate activity and immunosuppressive treatment]. (1971) (0)
Diaphragmatic muscle fiber type IIb/IIx dimensions are reduced in rats with biliary cirrhosis (1996) (0)
152 A prospective open, single arm, pilot trial to assess the safety and efficacity of orlistat in obese liver transplant patients (2004) (0)
Incomplete septal cirrhosis : a clinicopathological entity (1988) (0)
Viability of pig livers exposed to warm ischemia can be predicted prior to transplantation based on a morphological score (2007) (0)
Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System: Contribution of the Different Filters Inbuilt (2003) (0)
Relevance of understaging HCC by imaging prior to liver transplantation (2002) (0)
Machine perfusion of marginal human livers: hemodynamics, metabolism and morphology (2005) (0)
Asymmetric dimethyl-L-arginine (ADMA): a possible cause of endothelial dysfunction in the bile-duct excised cirrhotic rat (2005) (0)
Serum HCV-RNA, transaminases and HCV-antibodies in patients with chronic non-A, non-B hepatitis treated with interferon alpha-2B (IF) (1991) (0)
Reduction of portal pressure induced by subcutaneous somatostatine is not related to plasma glucagon suppression (1996) (0)
[Hepatitis C; current developments in diagnosis and therapy]. (1992) (0)
Hepatic hemangioma. (1980) (0)
Genetically characterized human liver cell lines (HEPG2) with distinct metabolic and toxicologic properties (2001) (0)
Disease profile, selection criteria and outcome of patients referred to intestinal transplantation: a center experience (2005) (0)
Alpha-interferon induces HBeAg− chronic active liver disease but improves long-term survival in HBeAg+ chronic active hepatitis patients (1998) (0)
Gene Therapy to Reduce Portal Hypertension : Possible Bridge to Liver Transplantation (2000) (0)
Association of infection with a specific hepatitis G virus strain with fulminant hepatitis (1998) (0)
Effects of Thyroid Hormone Administration and of Thyroidectomy on the Metabolism of Bilirubin in Rats (1987) (0)
Percutaneous transhepatic catheter drainage of the gallbladder for acute complicated cholecystitis in elderly patients and acalculous cholecystitis (1991) (0)
The prevalence of Transfusion Transmitted Virus (TTV) infection in Belgian population: an epidemiological study for the clinical significance (2000) (0)
Carcinoma at the hilus of the liver: clinical, radiological, histological and therapeutic aspects. (1982) (0)
Electronic mail-type multimedia communication of radiologic reports (1993) (0)
Liver transplantation (LTx) for polycystic liver disease (PLD) (1999) (0)
HSCs: hepatic stellate cells MLCK: Ca /calmodulin-dependent myosin light chain kinase rMLC: regulatory light chain of myosin PKC: protein kinase C MLCP: myosin light chain phosphatase IHVR: intrahepatic vascular resistance (2006) (0)
Indicaties, contra-indicaties en timing voor levertransplantatie (1993) (0)
Bile Pigments and Jaundice — Molecular, Metabolic and Medical Aspects, J. Donald Ostrow (Ed.). Marcel Dekker, Inc., Rijswijk, The Netherlands (1986), ISBN: 0-8247-7428-0 (1987) (0)
Excretion inDogBileofGlucose andXylose Conjugates ofBilirubin (1971) (0)
Terlipressin enhances free water clearance in CCl4 phenobarbital enhanced cirrhosis in the rat (1996) (0)
TheFateofBilirubin-IXa Glucuronide inCholestasis and during Storage invitro INTRAMOLECULAR REARRANGEMENT TO POSITIONALISOMERSOF GLUCURONIC ACID (1978) (0)
Progress in the treatment of acute variceal haemorrhage: The Leuven experience with TIPS. Emergencies in gastroenterology and hepatology (1996) (0)
Reversal of hepatorenal syndrome in 4 patients by peroral prostaglandin E 1 analogue and albumin (1989) (0)
Combination therapy of nitrates and spironolactone in the treatment of experimental portal hypertension (1995) (0)
The value of non-invasive tools to diagnose HCC or pre-malignant dysplastic nodules in patients with advanced cirrhosis and a hepatic mass (2004) (0)
153 The predictive value of non-invasive diagnostic tools to detect HCC or pre-malignant dysplastic nodules in patients with advanced cirrhosis and a hepatic mass (2004) (0)
Conjugation of bilirubin--pathophysiological aspects. (1976) (0)
Sa1438: TIME TO CHOLANGIOCARCINOMA IN PEDIATRIC ONSET PSC-IBD (2022) (0)
569 Quantitation of HCV positive- and negative strand RNA in liver tissue by strand-specific Taqman real-time PCR assays (2003) (0)
Completely steroid-free immunosuppression after liver transplantation (2000) (0)
Oesophageal varices. (2000) (0)
Parallel Sessions 31–41 (2007) (0)
Somatostatin for acute oesophageal variceal bleeding - Reply (1998) (0)
[Patients with liver cirrhosis and portal hypertension: survival after decompressive shunt operation]. (1978) (0)
Somatostatin inhibits theeffect ofsecretin on bile flow andon hepatic bilirubin transport intherat (1989) (0)
Hepatitis C. (1992) (0)
[The conjugation of bilirubin: clinico-experimental studies]. (1980) (0)
One year treatment with methotrexate (MTX) in patients with primary biliary cirrhosis (PBC) (1992) (0)
The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension (1995) (0)
1058 Phenotype-genotype correlations in patients with Wilson disease (WD) (2003) (0)
[Hepatic encephalopathy]. (1971) (0)
MELD is not superior to King's College hospital criteria in adult patients with non-acetaminophen induced acute liver failure (2006) (0)
Multiorgan transplantation (MOTX) including the liver (2001) (0)
ecNOS gene transfer enhances no production and NOS protein expression in the CCl4 cirrhotic rat liver resulting in prolonged decrease of portal pressure (2000) (0)
Ab initio completely steroid-free immunosuppression during and after liver transplantation: long-term 3 year follow-up report (2003) (0)
Extrahepatic manifestations of liver diseases (1991) (0)
The Diagnosis of Pancreatic Cancer (1985) (0)
Haemodynamic measurements in the cirrhotic rat should be performed in the freely moving rat (1995) (0)
[The significance of Child's criteria. Experience in the vascular surgery treatment of patients with liver cirrhosis and portal hypertension]. (1978) (0)
Non-heart-beating donors provide an additional source of organs for liver transplantation providing that the period of warm ischemia is kept short (2005) (0)
Other studies on liver disease (1992) (0)
Treatment of inoperable hepatocellular carcinoma (HCC) with selective regional chemotherapy:Clinical outcome (1991) (0)
In CCl4 cirrhosis but not in prehepatic portal hypertension or in biliary cirrhosis is a reduced expression of ceNOS found in rat liver (2000) (0)
Influence of intraoperative high-dose steroids on ischemia/reperfusion injury (IRI) after liver transplantation (2001) (0)
Liver failure requiring liver transplantation (LTx) following weight-reduction surgery for morbid obesity (2005) (0)
Detection of Hepatitis C virus antigen and Hepatitis C virus-RNA in liver biopsies of patients with chronic hepatitis C undergoing liver transplantation : a close correlation (1993) (0)
[Wilson's disease: description of various cases]. (1978) (0)
Book Reviews. (1976) (0)
Bilirubin metabolism. (1980) (0)
Combined treatment with methotrexate and ursodeoxycholic acid in primary biliary cirrhosis (PBC) (1996) (0)
A multifactorial protective strategy against warm ischemic injury of pig livers from non-heart-beating donors (2007) (0)
Valdidation of immunohistochemical staining with the monoclonal antibody 17H10 in liver biopsies for the diagnosis of chronic hepatitis C (2001) (0)
Does piecemeal necrosis in acute hepatitis predicts evolution to chronicity (1981) (0)
Early experience with the molecular absorbent recycling system (MARS) as a rescue treatment for liver failure (2001) (0)
DOES EX VIVO VASCULAR RESISTANCE REFLECT VIABILITY OF NON-HEART-BEATING LIVERS? (2004) (0)
SOMATOSTATIN FOR ACUTE OESOPHAGEAL VARICEAL BLEEDING. AUTHORS' REPLY (1998) (0)
A multimedia email system for communication between radiology and hepatology (1993) (0)
[Zieve's sydnrome]. (1976) (0)
White book hepatitis (1992) (0)
In Memoriam: Jan De Groote (1925–2018) (2018) (0)
Diagnosis of Hepatitis C virus infection in orthotopic liver transplant(olt) patients: the significance of detection of hepatitis C virus core antigen(Ag) in liver tissue by immunostaining (1994) (0)
[Bilirubin: metabolism, structure, and physiopathology]. (1974) (0)
Impact of Geographical Region on Death or Transplantation and on Malignancy in Primary Sclerosing Cholangitis - a Multicenter Retrospective Study of the International PSC Study Group (IPSCSG) (2018) (0)
Bile pigments and jaundice: Molecular, metabolic and medical aspects. Edited by J. Donald Ostrow. 744 pp. New York: Marcel Dekker, Inc., 1986. $119.50 (1987) (0)
Treatment of acute variceal bleeding: A review.Endoscopic diagnosis and treatment of gastrointestinal and hepatobiliary diseases (1998) (0)
Genetic polymorphisms in primary sclerosing cholangitis: a candidate gene study (2005) (0)
Effect of the cholangiographic agent, ioglycamide, on the beta-glucuronidase activity in rat liver and bile: relevance with regard to bilirubin deconjugation. (1986) (0)
[Angiographic aspects of portal hypertension in children (author's transl)]. (1976) (0)
Long-term outcome after TIPS procedure (1995) (0)
Biliary function in spontaneously diabetic BB rats (1991) (0)
Octreotide induces a negative water balance in healthy and cirrhotic rats during a salt load without changing arterial or portal pressure (1995) (0)
The effect of different bolus injections of somatostatin on the oesophageal intravariceal pressure in cirrhotic patients (1991) (0)
Desmin expressing cells during embryonic hepatic hematopoiesis in rat (1995) (0)
1289 CHOLESTASIS-ASSOCIATED PRURITUS TREATED WITH UVB PHOTOTHERAPY: REPORT OF 13 CASES (2011) (0)
Liver and brain: is there a link? (2010) (0)
Combined bile duct excision-formalin injection: a model to study progressive (vanishing) bile duct disease (2001) (0)
A new ultrastructural feature in non-A, non-B hepatitis (1982) (0)
Characterization oftheMajor Diazo-Positive Pigments inBile of Homozygous GunnRats (1977) (0)
A comparison of different methods of ultrasonic assessment of transjugular intrahepatic portosystemic shunt dysfunction (1996) (0)
[Digestive angiography: critical evaluation. Liver tumors]. (1975) (0)
[Drug metabolism and liver toxicity]. (1977) (0)
Halofuginone treatment might aggravate fibrosis in a rat model of biliary cirrhosis (2003) (0)
A wide interindividual difference between portal and variceal pressureexplains the lack of correlation between portal pressure andvariceal haemorrhage (2000) (0)
500 liver transplantations in a 10 year-period: progresses & remaining problems (2008) (0)
Apparent maximal biliary secretion (‘Tm’) of bilirubin in the rat: Dependehce on conjugation and on bile flow (1978) (0)
Treatment of decompensated viral hepatitis B induced liver cirrhosis with low dose interferon alpha (IFN) (1991) (0)
Clinical Aspects of Incomplete With Macronodular Cirrhosis (1994) (0)
Embolization of spontaneous portosystemic shunts in cirrhotic patients with refractory hepatic encepalopathy : results of a single center prospective exploratory study (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Johan M. J. Fevery?

Johan M. J. Fevery is affiliated with the following schools:

Johan M. J. Fevery's Academic­Influence.com Rankings

Johan M. J. Fevery's Degrees

Why Is Johan M. J. Fevery Influential?

Johan M. J. Fevery's Published Works

Published Works

What Schools Are Affiliated With Johan M. J. Fevery?

Johan M. J. Fevery's AcademicInfluence.com Rankings